Immunosuppressants - PDFSEARCH.IO - Document Search Engine

Immunosuppressants
Results: 1821

#	Item
91	CrossMark_Color_flat+click Add to Reading List Source URL: www.pnas.org Language: English - Date: 2014-12-26 02:50:18 Immunology T cells Glycoproteins Immunosuppressants Sirolimus Polyclonal antibodies T helper cell B cell Co-stimulation Biology Anatomy Immune system
92	s p e c i a l f e at u r e © John Bavosi / Photo Researchers, Inc. Osteoarthritis and Rheumatoid Arthritis 2012: Add to Reading List Source URL: www.nphealthcarefoundation.org Language: English - Date: 2012-10-29 11:36:28 Anatomy Rheumatology Immunosuppressants Connective tissue diseases Autoimmune diseases Rheumatoid arthritis Osteoarthritis Disease-modifying antirheumatic drug Tofacitinib Health Medicine Arthritis
93	1 INTERIM FUNDING CRITERIA IN ONTARIO FOR SOLIRIS AHUS –CASE BY CASE BASIS Initiation Criteria A patient must meet all three of the following to obtain funding for initial treatment of eculizumab for aHUS: 1. Confirmed Add to Reading List Source URL: www.ahuscanada.org Language: English - Date: 2015-03-19 14:38:28 Syndromes Eculizumab Hemolytic-uremic syndrome Thrombocytopenia Nephrology Renal function Meningococcal disease Medicine Health Immunosuppressants
94	Modulators of the interaction of Astrin and Raptor, and uses thereof in cancer therapy Technology Mammalian target of rapamycin complex 1 (mTORC1) controls growth and survival in response to metabolic cues. Oxidative str Add to Reading List Source URL: www.campus-technologies.de Language: English - Date: 2014-09-16 07:06:51 Signal transduction Immunosuppressants Macrolides Apoptosis Sirolimus Oxidative stress Stress granule Stress Biology Cell biology Mammalian target of rapamycin
95	Novartis Pharmaceuticals Canada Inc. 385 Bouchard Boulevard Dorval, Quebec H9S 1A9 www.novartis.ca http://www.novartis.com Add to Reading List Source URL: www.novartis.ca Language: English - Date: 2015-05-13 10:22:08 Arthritis Rheumatology Immunosuppressants Psoriasis Rheumatoid arthritis Ankylosing spondylitis Psoriatic nails Psoriatic arthritis Secukinumab Medicine Health Autoimmune diseases
96	mTOR Signaling in Growth Control and Disease Add to Reading List Source URL: sabatinilab.wi.mit.edu Language: English - Date: 2015-04-21 13:18:30 Macrolides Immunosuppressants Mammalian target of rapamycin Growth factors Protein kinases AKT Everolimus Sirolimus Class III PI 3-kinase Biology Biochemistry Signal transduction
97	Microsoft PowerPoint - ASH 536 MDS Oral Presentation FINAL.pptx Add to Reading List Source URL: www.acceleronpharma.com Language: English - Date: 2014-12-07 14:11:30 Myelodysplastic syndrome Anemias Erythropoietin Celgene Anemia Medicine Immunosuppressants Lenalidomide
98	Avaxia Biologics Awarded Patent with Broad Coverage over Oral Anti-TNF Antibodies for Inflammatory Bowel Disease LEXINGTON, Mass. – February 11, 2014 – Avaxia Biologics, Inc., a clinical-stage biopharmaceutical compa Add to Reading List Source URL: www.avaxiabiologics.com Language: English - Date: 2014-02-11 13:20:44 Gastroenterology Monoclonal antibodies Abdominal pain Immunology Immunosuppressants Inflammatory bowel disease TNF inhibitor Ulcerative colitis Biologic Medicine Health Autoimmune diseases
99	Microsoft Word - 12D030-PRT-WPI.doc Add to Reading List Source URL: www.us.astellas.com Language: English - Date: 2013-08-21 15:23:36 Type 1 hypersensitivity Tacrolimus Immune system Medicine Atopic dermatitis Atopy Interleukin 2 Immunology Immunosuppressants Macrolides
100	Avaxia Biologics To Present AVX-470 Phase 1b Clinical Results at Upcoming Medical Conferences LEXINGTON, Mass. – October 17, 2014 – Avaxia Biologics, Inc., a clinical-stage biopharmaceutical company developing gut-ta Add to Reading List Source URL: www.avaxiabiologics.com Language: English - Date: 2014-10-22 17:46:37 Immunology Monoclonal antibodies Abdominal pain Immunosuppressants Inflammatory bowel disease Ulcerative colitis TNF inhibitor Biologic Colitis Medicine Health Autoimmune diseases

UPDATE